Pingora Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.16M Hold
89,510
1.26% 17
2026
Q1
$2.51M Buy
89,510
+5,650
+7% +$150K 1.49% 12
2025
Q4
$2.09M Buy
83,860
+2,692
+3% +$67.9K 1.28% 13
2025
Q3
$2.07M Sell
81,168
-1,230
-1% -$30.4K 1.37% 13
2025
Q2
$2M Sell
82,398
-1,170
-1% -$27.3K 1.49% 14
2025
Q1
$2.12M Sell
83,568
-1,150
-1% -$30.1K 1.57% 10
2024
Q4
$2.25M Buy
84,718
+16,748
+25% +$454K 1.47% 10
2024
Q3
$1.97M Buy
67,970
+21,275
+46% +$621K 1.39% 9
2024
Q2
$1.31M Buy
46,695
+12,105
+35% +$333K 0.93% 22
2024
Q1
$960K Buy
34,590
+280
+0.8% +$7.77K 0.7% 30
2023
Q4
$988K Buy
+34,310
New +$1.04M 0.87% 29

Other funds holding PFE

Pingora Partners's PFE Position: Q2 2026 in Review

Pingora Partners held its Pfizer (PFE) position steady in Q2 2026 at 89,510 shares worth $2.16M. The position accounts for 1.26% of the portfolio, ranked #17.

Pingora Partners first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.51M in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Pingora Partners held 89,510 shares of Pfizer worth $2.16M as of Q2 2026.
  • Pingora Partners left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 1.26% of Pingora Partners's portfolio in Q2 2026, its #17 holding.
  • Pingora Partners first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Pingora Partners's Pfizer position peaked at $2.51M in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Pingora Partners's 13F filing for Q2 2026, filed 14 Aug 2026.